News

Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Novartis works closely with healthcare professionals around the world to support ...
The mental health and wellbeing of our people is vitally important. It is a natural extension of our company’s purpose to discover new ways to improve and extend people’s lives. Our ambition at ...
V Novartisu spodbujamo inovativnost in razvoj ter delujemo na številnih področjih. Tudi vi lahko postanete del tega, del naše zgodbe. Pridružite se naši ustvarjalni skupnosti strokovnjakov in našli ...
At Novartis, we innovate, develop and operate on a vast scale. You can be part of it. Join our creative community of professionals and you will find opportunities to make an unprecedented impact – on ...
Εξερευνήστε ευκαιρίες στη Novartis και στη Sandoz παρακάτω. Για επιπλέον ρόλους στη Novartis Gene Therapies (πρώην AveXis) επισκεφτείτε την Αναζήτηση ...
Territory Business Executive Regular (Sales), Full time Universal Hierarchy Node Indien Gujarat Mai 30, 2025 ...
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the ...
Regulus filed a solicitation/recommendation statement on Schedule 14D-9 with the SEC, which includes, among other things, the recommendation of Regulus’s board of directors that Regulus’s stockholders ...
Hos Novartis er våre talentfulle og motiverte ansatte nøkkelen til å utvikle nye legemidler og bringe dem ut til pasientene. Trivsel på jobben Les om våre globale tiltak for trivsel på jobben.
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
Sort by Sort ascending 職種Sort ascending 部門国勤務地掲載日 職種Sort ascending 部門国勤務地掲載日 Digital Disease PartnerRegular (Sales), Full time Innovative Medicines Saudi Arabia Jeddah Jun 01, 2025 Business Operations ...